Some four years into Jemperli’s commercial lifespan, a rift has emerged between GSK subsidiary Tesaro and the potential cancer blockbuster’s original developer, AnaptysBio. | Some four years into ...

GSK has escalated a dispute over rights to its cancer immunotherapy Jemperli, after its subsidiary Tesaro filed a complaint ...

GSK has picked a novel protein biotech and a genomics biotech as its first collaborators under a $7 billion biobucks deal ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...

AnaptysBio has separately alleged that GSK subsidiary Tesaro breached “certain requirements” under their 2014 license agreement involving a program that would become GSK's Jemperli.

(Reuters) -Shares of AnaptysBio fell 14% in premarket trading on Friday after the U.S. drug developer and Tesaro, a unit of ...

London: GSK plc and LTZ Therapeutics, an immunotherapy-focused biotechnology company based in Redwood City, California, have ...

GSK's Tesaro sues AnaptysBio over alleged Jemperli contract breaches, putting royalties, milestones, and future licensing ...

Sino-American immunotherapy-focused biotech LTZ Therapeutics and UK pharma major GSK have entered into a strategic research ...

Producer Guy King has doubled sow numbers from 500 to 1,000, and the 2023 Farmers Weekly Pig Farmer of the Year is now ...

GSK & LTZ announce strategic collaboration to advance novel myeloid cell engagers in oncology: London, UK Thursday, November 20, 2025, 09:00 Hrs [IST] GSK plc and LTZ Therapeutics ...